- Title
- Adherence to treatment of osteoporosis : a need for study
- Creators - without role
- F Lekkerkerker - Medicines Evaluation BoardJ. A Kanis - University of SheffieldN Hughes - AmgenJ.-M Kaufman - Ghent University HospitalS Korte - NovartisG Kreutz - Council for International Organisations of Medical Sciences, Geneva, SwitzerlandA Laslop - Austrian Medicines and Medical Devices Agency, Vienna, AustriaB Mitlak - Eli LillyV Rabenda - Centre Hospitalier Universitaire de LiègeR Rizzoli - Centre Collaborateur de l'Oms pour la prevention de l'osteoporose, Geneva, SwitzerlandA Santora - MSDR Schimmer - RocheN Alsayed - Supreme S.A, Liège, BelgiumY Tsouderos - ServierP Viethel - Merck-Theramex, Monaco, MonacoJ.-Y Reginster - University of LiègeG Bouvenot - French National Authority for Health-Transparency Committee, Paris, FranceN Burlet - International Osteoporosis Foundation, Nyon, SwitzerlandD Cahall - SanofiA Chines - Wyeth Research, Philadelphia, PA, United StatesP Delmas - Hôpital Edouard HerriotR.-L Dreiser - Hôpital Bichat-Claude-BernardD Ethgen - GlaxoSmithKlineGroup for the Respect of Ethics and Excellence in Science (GREES)
- Publication Details
- Osteoporosis international, Vol.18(10), pp.1311-1317
- Publisher
- Springer
- Identifiers
- 9947717008331
- Academic Unit
- King Saud University
- Language
- English
- Resource Type
- Journal article
Journal article
Adherence to treatment of osteoporosis : a need for study
Osteoporosis international, Vol.18(10), pp.1311-1317
01/10/2007
PMID: 17585359
Metrics
1 Record Views